Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2021

Open Access 01-12-2021 | Fluorescence in Situ Hybridization | Research

Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review

Authors: Ling-Ling Wang, Zhong-He Ji, Ying Gao, Hong Chang, Ping-Ping Sun, Yan Li

Published in: World Journal of Surgical Oncology | Issue 1/2021

Login to get access

Abstract

Background and purpose

Desmoplastic small round cell tumor (DSRCT) is a highly malignant sarcoma that occurs in the abdominopelvic cavities of adolescents. The accurate diagnosis of DSRCT is challenging owing to limited literatures. Our study aimed to investigate the relationship between clinicopathological features and prognosis in patients with DSRCTs.

Methods

Data of 8 patients with DSRCT originating from the abdominal cavity were retrospectively reviewed. The clinical manifestations, pathological characteristics, treatment approaches, and prognosis were analyzed. The histopathological (identified using hematoxylin-eosin staining), immunohistochemical, and molecular diagnostic (using fluorescence in situ hybridization) features were also reviewed.

Results

All patients were male aged between 24 and 45 years (median age, 30 years). The main clinical symptoms included abdominal distension, abdominal pain, and constipation. Seven of the 8 patients developed metastases to either distant organs or lymph nodes. Multiple gray nodules with diameters of 1–10 cm and poorly defined boundaries were scattered throughout the omentum and mesentery. Histopathological examination demonstrated well-defined nests composed of small round blue cells separated by markedly desmoplastic stroma. Immunohistochemical analysis revealed positive expressions of desmin, vimentin and C-terminal of Wilm’s tumor suppressor (WT-1). The Ewing sarcoma breakpoint region 1 gene fused with WT1 (EWSR1-WT1) gene fusion was detected in all patients. Cytoreductive surgery (CRS) was performed in 6 patients. Follow-up period ranged from 7.5 to 28.5 months with a median of 17.2 months. Three patients died during follow-up.

Conclusion

DSRCT is highly aggressive and presents distinctive morphological features. CRS is the essential therapy for DSRCT. A test for the combined expression of desmin, cytokeratins, and C-terminal of WT-1, as well as the analysis of morphologic features, might be helpful during DSRCT diagnosis, and the EWSR1-WT1 gene fusion is the gold standard for definitive diagnosis. Our work will provide new insights into the diagnosis and treatment of DSRCTs.
Literature
20.
go back to reference Hill DA, Pfeifer JD, Marley EF, Dehner LP, Humphrey PA. Zhu X, Swanson PE: WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study. American journal of clinical pathology. 2000;114(3):345–53. https://doi.org/10.1093/ajcp/114.3.345.CrossRefPubMed Hill DA, Pfeifer JD, Marley EF, Dehner LP, Humphrey PA. Zhu X, Swanson PE: WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study. American journal of clinical pathology. 2000;114(3):345–53. https://​doi.​org/​10.​1093/​ajcp/​114.​3.​345.CrossRefPubMed
Metadata
Title
Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review
Authors
Ling-Ling Wang
Zhong-He Ji
Ying Gao
Hong Chang
Ping-Ping Sun
Yan Li
Publication date
01-12-2021
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2021
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-021-02310-6

Other articles of this Issue 1/2021

World Journal of Surgical Oncology 1/2021 Go to the issue